View Author
Paulij, W.
( W. Paulij)
9 h 9 hbsag 4-7 b 4-7 hbs.ot assay phase patient hbeag sample hepatitis anti- chimpanzee antibody serum hbs.ot 40 anti-hb mouse conjugate amount chimpanzee hbsag inhibition infection selection assay result virus level anti-pre complex epitope hbs.ot 42 experiment hepatitis b dilution treatment mouse hbs.ot 40 hepatitis b virus heijtink signal particle phase anti-pres 1 phase anti-s selection hepatitis b infection binding hbsag particles abbott laboratories pres 1 protein infusion 30 min sample 30 min organon teknika protein peptide curve hbs.ot 3m incubation teknika chronicity hbv dna levels phase hbs.ot 3m serum samples organon liver transplant recipients antigen phase mouse ivf treatment study detection activity hbv dna hbeag signal disease chimpanzee pre-treatment hbsag 6 ng \ml concentration hbeag-positive surface 9 h 9\4-7b 4-7 b antibodies
2 Most Recent Publications
|
Characteristics of early phase of chronicity in acute hepatitis B infection.
(Article)
Heijtink, R.A. Paulij, W. Roosmalen, M.H. van Hellings, J.A. Schalm, S.W. Osterhaus, A.D.M.E. Niesters, H.G.M. |
1999-01-01
|
|
In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee
(Article)
Heijtink, R. Paulij, W. Bergen, P. van Roosmalen, M.H. van Rohm, D. Eichentopf, B. Muchmore, E. Osterhaus, A.D.M.E. Man, R.A. de |
1999-01-01
|
